Deferred Tax Assets, Valuation Allowance of Skye Bioscience, Inc. from 31 Oct 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Skye Bioscience, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Oct 2012 to 31 Dec 2025.
  • Skye Bioscience, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $74,334,787, a 9.7% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Skye Bioscience, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $74,334,787 +$6,591,212 +9.7% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q4 2024 $67,743,575 +$1,282,018 +1.9% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q4 2023 $66,461,557 +$22,504,068 +51% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q4 2022 $43,957,489 +$34,583,912 +369% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q4 2021 $9,373,577 +$1,783,362 +23% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $7,590,215 +$1,383,765 +22% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q4 2019 $6,206,450 +$903,969 +17% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q4 2018 $5,302,481 +$1,286,994 +32% 31 Dec 2018 10-K 23 Mar 2020 2019 FY
Q4 2017 $4,015,487 -$344,321 -7.9% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q4 2016 $4,359,808 +$1,720,620 +65% 31 Dec 2016 10-K 19 Mar 2018 2017 FY
Q4 2015 $2,639,188 +$1,614,066 +157% 31 Dec 2015 10-K 10 Mar 2017 2016 FY
Q4 2014 $1,025,122 31 Dec 2014 10-K 21 Mar 2016 2015 FY
Q3 2012 $1,377* 31 Oct 2012 10-Q 27 Jun 2013 2013 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.